Dihydroergotamine Mesylate and Paliperidone Extended-Release Tablets
Determining the interaction of Dihydroergotamine Mesylate and Paliperidone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: paliperidone
Brand name: Invega, Invega Sustenna, Invega Trinza
Synonyms: Paliperidone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Paliperidone injection
- Dihydroergotamine Mesylate-Paliperidone Intramuscular
- Dihydroergotamine Mesylate-Palladone
- Dihydroergotamine Mesylate-Palmitate-A
- Dihydroergotamine Mesylate-Palonosetron
- Dihydroergotamine Mesylate-Palonosetron Hydrochloride
- Paliperidone Extended-Release Tablets-Dihydroergotamine nasal
- Paliperidone Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Paliperidone Extended-Release Tablets-Dilacor XR
- Paliperidone Extended-Release Tablets-Dilantin
- Paliperidone Extended-Release Tablets-Dilantin Infatabs
- Paliperidone Extended-Release Tablets-Dilantin injection